Results 231 to 240 of about 1,148,634 (348)

Data sources used in bibliometrics 1978–2022: From proprietary databases to the great wide open

open access: yesJournal of the Association for Information Science and Technology, EarlyView.
Abstract Traditionally, the bibliometric community has relied heavily on secondary data sources, most prominently the Science Citation Index. By analyzing three key journals, we detected trends in the data sources used over a 45‐year period (1978–2022).
Camilla Hertil Lindelöw   +2 more
wiley   +1 more source

Wearable exoskeleton robot control using radial basis function‐based fixed‐time terminal sliding mode with prescribed performance

open access: yesAsian Journal of Control, EarlyView.
Abstract This paper tackles the problem of robust and accurate fixed‐time tracking in human–robot interaction and deals with uncertainties. This work introduces a control approach for a wearable exoskeleton designed specifically for rehabilitation tasks.
Mahmoud Abdallah   +4 more
wiley   +1 more source

Conservative Treatment of Neonatal Brachial Plexus Palsy: A Narrative Review. [PDF]

open access: yesJ Clin Med
Boetto V   +9 more
europepmc   +1 more source

Sodium Manganese Hexacyanoferrate: Characterization as Sodium‐Ion Battery Cathode Material, Full Cell Cycling with Hard Carbon and Post‐Mortem Analyses

open access: yesBatteries &Supercaps, EarlyView.
Sodium manganese hexacyanoferrate (NaMnHCF) is a promising cathode for sodium‐ion batteries due to its LFP‐like voltage profile and cost‐effective composition. This study examines its cycling performance with hard carbon anodes, highlighting Na+ inventory loss as a key degradation factor.
Sebastian Büchele   +15 more
wiley   +1 more source

Outcome of Conservative Treatment of Odontoid Fractures in Elderly Patients Over 80 Years Old. [PDF]

open access: yesGeriatr Orthop Surg Rehabil
Speldova A   +4 more
europepmc   +1 more source

Drug–drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To assess the effect of a potent cytochrome P450 (CYP) 3A inhibitor and CYP inducer on the pharmacokinetics of ritlecitinib, a JAK3/TEC family kinase inhibitor, and assess the effect of ritlecitinib on the pharmacokinetics of CYP substrates (midazolam, efavirenz, tolbutamide, caffeine and oral contraceptives [ethinyl oestradiol and levonorgestrel])
Vivek S. Purohit   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy